mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.004 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.004 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.004 |
mRNA |
BRD-K66453893 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.005 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.006 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.008 |